|
NEURODEGENERATION IN AGING DOWN SYNDROME (NIAD): A LONGITUDINAL STUDY OF COGNITION AND BIOMARKERS OF ALZHEIMER'S DISEASE |
5U01AG051406-02 |
HANDEN, BENJAMIN L |
NIA |
2016 |
|
BIOMARKERS OF ALZHEIMER'S DISEASE IN ADULTS WITH DOWN SYNDROME |
5U01AG051412-02 |
SCHUPF, NICOLE |
NIA |
2016 |
|
MUSCLE MASS AND STRENGTH CUTPOINTS IN PERSONS AT RISK OF MOBILITY DISABILITY |
5U01AG051421-02 |
BHASIN, SHALENDER |
NIA |
2016 |
|
2016-2018 DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCES |
5U13AG052268-02 |
FILLIT, HOWARD M. |
NIA |
2016 |
|
RISK FACTORS AND PREVENTION TARGETS FOR ABNORMAL COGNITIVE AGING |
6K24AG046373-04 |
JEFFERSON, ANGELA L. |
NIA |
2016 |
|
CARDIAC FUNCTION AS A MECHANISM FOR MALADAPTIVE BRAIN AGING |
6R01AG034962-07 |
JEFFERSON, ANGELA L. |
NIA |
2016 |
|
THE ROLE OF AGING IN LRRK2-ASSOCIATED PARKINSONS DISEASE |
7K01AG046366-03 |
XIONG, YULAN |
NIA |
2016 |
|
GENERALIZATION OF FUNCTIONAL TASK-SPECIFIC MOTOR TRAINING IN OLDER ADULTS |
7K01AG047926-03 |
SCHAEFER, SYDNEY YOSHIE |
NIA |
2016 |
|
ASSOCIATIONS BETWEEN IDEAL CARDIOVASCULAR HEALTH, FRAILTY & AGE RELATED DECLINES |
7R03AG048377-02 |
TALEGAWKAR, SAMEERA A |
NIA |
2016 |
|
IN-SITU LEAD TESTER FOR IMPLANTABLE DEVICES |
9R44AG055056-02A1 |
LICHTER, PATRICK ALLAN |
NIA |
2016 |